These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27440962)

  • 1. Health Inequities in Hypertension and Related Organ Damage.
    Mensah GA
    Ethn Dis; 2016 Jul; 26(3):263-6. PubMed ID: 27440962
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF
    Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of target organ damage in Taiwanese with white coat hypertension.
    Tseng YZ; Chiang FT; Hsu KL; Lo HM; Tseng CD; Lin JL; Hwang JJ; Lai LP
    J Formos Med Assoc; 2005 May; 104(5):327-32. PubMed ID: 15959599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension, Blood Pressure Variability, and Target Organ Lesion.
    Irigoyen MC; De Angelis K; Dos Santos F; Dartora DR; Rodrigues B; Consolim-Colombo FM
    Curr Hypertens Rep; 2016 Apr; 18(4):31. PubMed ID: 27002717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of target organ damage in patients treated for primary arterial hypertension: Comparison between men and women. ESSENTIELLE study].
    Boivin JM; Koch C; Vigié L; Meppiel L
    Ann Cardiol Angeiol (Paris); 2015 Jun; 64(3):150-7. PubMed ID: 26049900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise blood pressure and target organ damage in essential hypertension.
    Fagard R; Staessen J; Amery A
    J Hum Hypertens; 1991 Apr; 5(2):69-75. PubMed ID: 2072369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function: The Second Manifestations of Arterial Disease-Magnetic Resonance Study.
    van der Veen PH; Geerlings MI; Visseren FL; Nathoe HM; Mali WP; van der Graaf Y; Muller M;
    Hypertension; 2015 Dec; 66(6):1152-8. PubMed ID: 26503971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure biofeedback treatment, organ damage and sympathetic activity in mild hypertension.
    Nakao M; Nomura S; Shimosawa T; Fujita T; Kuboki T
    Psychother Psychosom; 1999; 68(6):341-7. PubMed ID: 10559715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring and target organ damage in pediatrics.
    Stabouli S; Kotsis V; Zakopoulos N
    J Hypertens; 2007 Oct; 25(10):1979-86. PubMed ID: 17885534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and end-organ damage in elderly hypertensives.
    Shimada K; Miyashita H; Kawamoto A; Matsubayashi K; Nishinaga M; Kimura S; Ozawa T
    J Hypertens Suppl; 1994 Sep; 12(6):S7-12. PubMed ID: 7799109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis.
    Bliziotis IA; Destounis A; Stergiou GS
    J Hypertens; 2012 Jul; 30(7):1289-99. PubMed ID: 22499289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.
    Muñoz-Durango N; Fuentes CA; Castillo AE; González-Gómez LM; Vecchiola A; Fardella CE; Kalergis AM
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs.
    Xie HH; Shen FM; Zhang XF; Jiang YY; Su DF
    Eur J Pharmacol; 2006 Aug; 543(1-3):77-82. PubMed ID: 16808912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.